Directors and Advisers

Directors

Julian Baines, Non-Executive Chairman

Group CEO, EKF Diagnostics Holdings plc; former CEO & Managing Director BBI Holdings plc

James McCullough, MBA, CEO

Partner, Renwick Capital; former CEO, Exosome Diagnostics; co-Founder PAIGE.AI

Richard Evans, MBA

CFO EKF Diagnostics Holdings plc; Finance Manager, Global Account Director at Hitachi Data Systems

Christopher Mills

CEO and Partner, Harwood Capital LLP; CEO and Investment Manager North Atlantic Smaller Companies Investment Trust

Fergus Fleming, CTO

Managing Director, FF Consulting; former senior project manager, EKF Diagnostics Holdings plc

Barbara Murphy, MD

Murray M. Rosenberg Professor of Medicine; Chair of the Department of Medicine for the Mount Sinai Health System; Dean for Clinical Integration and Population Health

Erik Lium, PhD

Executive Vice President, Innovation Partners, Mount Sinai Health System

Senior Managers

O. James Sterling, CFO

Partner, Renwick Capital; former Managing Director, Brock Capital Group and Aleutian Capital Partners; management consultant, Booz Allen

Sally Bowden, COO

President of Bowden Consulting Group, Inc., focussing on quality and regulatory field in medical devices, companion diagnostics, education and health care systems.

Michael J. Donovan, PhD, MD

Graduate from Rutgers University with a B.S. in zoology, a M.S. in endocrinology and a PhD in cell and developmental biology with post-doctoral studies at Harvard Medical School. He received his M.D. from the University of Medicine and Dentistry of New Jersey.

Advisory Board

Barbara Murphy, MD, Chair of Advisory Board

Murray M. Rosenberg Professor of Medicine; Chair of the Department of Medicine for the Mount Sinai Health System; Dean for Clinical Integration and Population Health

Steve Coca, DO, co-Founder

Associate Professor, Medicine, Nephrology; Associate Chair for Clinical and Translational Research for the Department of Internal Medicine, Mount Sinai Health System

Girish Nadkarni, MD, co-Founder

Assistant Professor of Medicine, Division of Nephrology; Clinical Director of the Charles Bronfman Institute for Personalized Medicine Mount Sinai Health System

Judy Cho, MD

Director and Associate Dean for Precision Medicine, Ward-Coleman Professor of Translational Genetics and Medicine Mount Sinai Health System.

John Cijiang He, MD

Professor of Medicine and Pharmacological Sciences, Irene; Dr. Arthur Fishberg endowed Chair of Nephrology, Mount Sinai Health System

Chirag R Parikh, MD, PhD

Director, Division of Nephrology, Ronald Peterson Professor of Medicine, Johns Hopkins School of Medicine

Joseph Boystak

Managing partner at Health2047 Capital Partners and managing director of Corporate Development at Health2047 Inc. Chair and co-chief executive of NanoPacific Holdings, Inc., Founder of Brightwaters Capital, LLC.

John Quackenbush, PhD

Professor of Computational Biology and Bioinformatics, Harvard T.H. Chan School of Public Health; Professor of Cancer Biology, Dana-Farber Cancer Institute

Joseph V. Bonventre MD PhD

Samuel A. Levine Professor of Medicine, Harvard Medical School. Chief of the Division of Renal Medicine and Chief of the Biomedical Engineering Division, Brigham and Women’s Hospital (BWH)

Company Secretary

Salim Hamir, FCA

Chartered Accountant, Company Secretary and Head of Corporate Affairs EKF Diagnostics Holdings Plc

Advisors

Media & Investor Relations

Tel: +44 (0)20 7933 8780
renalytix@walbrookpr.com

Walbrook PR Limited
4 Lombard Street
London
EC3V 9HD

latest News

14Feb

Appointment of Nomad and Joint Broker

Renalytix AI announces the appointment of Stifel as the Company’s nominated adviser and joint broker with immediate effect. N+1 Singer will continue to act as.. Read More →
13Feb

RenalytixAI and AKESOgen In Joint Venture Partnership for Expanded Testing Capacity and Pharma Services

Renalytix AI announces the completion of a joint venture partnership agreement with AKESOgen, an industry-leading commercial laboratory facility and provider of clinical trial precision medicine services located in.. Read More →
06Feb

RenalytixAI Expands Leadership Team to Support Launch of AI-Enabled Diagnostics for Kidney Disease

Company Adds Clinical and Data Security Expertise to Support KidneyIntelX Clinical Validation, Software and Regulatory Programmes.. Read More →